Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.45 is 40% below its 5-year average of 9.02, near the low end of its 5-year range (3.06–16.36).
As of the fiscal period ended Tuesday, June 30, 2026. 26.44% above its 12-month average of 4.31.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.45.
QUICK RATIO (ACID-TEST)
5.45
QUICK RATIO (ACID-TEST) AVG TTM
4.31
QUICK RATIO (ACID-TEST) AVG 3Y
6.69
QUICK RATIO (ACID-TEST) AVG 5Y
9.02
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+26.44%
CURRENT VS 3Y AVG
-18.52%
CURRENT VS 5Y AVG
-39.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 792 covered companies
CURRENT VS SECTOR MEDIAN
+66.08%
vs the sector median at left
Hyperfine, Inc.
Market Cap
$76.69M
Quick Ratio (Acid-Test)
5.45
TTM Avg
4.31
3Y Avg
6.69
5Y Avg
9.02
Market Cap
$77.15M
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.80
3Y Avg
2.98
5Y Avg
4.38
Market Cap
$77.80M
Quick Ratio (Acid-Test)
0.14
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.07
Market Cap
$76.19M
Quick Ratio (Acid-Test)
4.11
TTM Avg
4.89
3Y Avg
5.09
5Y Avg
6.08
Market Cap
$76.14M
Quick Ratio (Acid-Test)
1.48
TTM Avg
3.70
3Y Avg
5.52
5Y Avg
5.98
Market Cap
$78.35M
Quick Ratio (Acid-Test)
3.52
TTM Avg
4.58
3Y Avg
5.82
5Y Avg
8.88
Market Cap
$79.24M
Quick Ratio (Acid-Test)
1.00
TTM Avg
2.08
3Y Avg
2.75
5Y Avg
4.86
Market Cap
$79.04M
Quick Ratio (Acid-Test)
0.34
TTM Avg
0.10
3Y Avg
0.26
5Y Avg
0.26
Market Cap
$80.78M
Quick Ratio (Acid-Test)
4.02
TTM Avg
5.44
3Y Avg
3.75
5Y Avg
3.66
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $76.69M | 5.45 | 4.31 | 6.69 | 9.02 |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | 1.98 | 1.80 | 2.98 | 4.38 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.80M | 0.14 | 0.07 | 0.07 | 0.07 |
| Outset Medical, Inc. (OM)vs › | $76.19M | 4.11 | 4.89 | 5.09 | 6.08 |
| SkinHealth Systems Inc. (SKIN)vs › | $76.14M | 1.48 | 3.70 | 5.52 | 5.98 |
| Pulmonx Corporation (LUNG)vs › | $78.35M | 3.52 | 4.58 | 5.82 | 8.88 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.24M | 1.00 | 2.08 | 2.75 | 4.86 |
| Citius Oncology, Inc. (CTOR)vs › | $79.04M | 0.34 | 0.10 | 0.26 | 0.26 |
| Nutriband Inc. (NTRB)vs › | $80.78M | 4.02 | 5.44 | 3.75 | 3.66 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $81.86M | 7.99 | 9.12 | 12.06 | 14.25 |
Quick Ratio
5.45
Excludes inventory
Current Ratio
6.15
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.45 |
| 2026-03-31 | 4.90 |
| 2025-12-31 | 3.73 |
| 2025-09-30 | 3.06 |
| 2025-06-30 | 4.41 |
| 2025-03-31 | 5.48 |
| 2024-12-31 | 5.48 |
| 2024-09-30 | 5.73 |
| 2024-06-30 | 7.24 |
| 2024-03-31 | 8.26 |
| 2023-12-31 | 9.39 |
| 2023-09-30 | 11.12 |
| 2023-06-30 | 12.67 |
| 2023-03-31 | 13.92 |
| 2022-12-31 | 14.09 |
| 2022-09-30 | 11.21 |
| 2022-06-30 | 14.58 |
| 2022-03-31 | 14.82 |
| 2021-12-31 | 12.28 |
| 2021-09-30 | 5.32 |
| 2021-06-30 | 16.36 |
| 2021-03-31 | 11.70 |
| 2020-12-31 | 16.18 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
